Life Bio reaches first clinical milestone for OSK therapy

First patient dosed in Phase 1 trial testing epigenetic restoration approach for progressive age-related vision loss. The longevity field has spent much of the past decade debating whether aging can be modified at the level of cellular identity itself. Now, one of the sector’s most closely watched theories is taking an important step into the […] The post Life Bio reaches first clinical milestone for OSK therapy appeared first on Longevity.Technology .

This story was reported by Longevity.Technology. EUROPES curates Europe's most relevant coverage — read the full report at the original source.